Stock PILA PILA PHARMA AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Pila Pharma AB

Equities

PILA

SE0015988274

Market Closed - Nasdaq Stockholm
Other stock markets
 11:19:42 2024-05-31 EDT 		5-day change 1st Jan Change
3.1 SEK +2.99% Intraday chart for Pila Pharma AB +10.71% +93.75%
04-19 Pila Pharma Appoints New CEO, Chief Scientific Officer MT
04-19 Pila Pharma AB Announces Board and Management Appointments CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pila Pharma Appoints New CEO, Chief Scientific Officer
MT
Pila Pharma AB Announces Board and Management Appointments
CI
Pila Pharma AB Announces CEO Changes
CI
Pila Pharma Nominates CEO as Chair
MT
Pila Pharma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Pila Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Pila Pharma Enters Research Collaboration to Study Heart Disease Treatment in Mice
MT
Pila Pharma AB Enters Research Collaboration with the Research Group of Professor Dick Wagsater, Uppsala University, Sweden
CI
Pila Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Pila Pharma AB announced a financing transaction
CI
Pila Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Pila Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Pila Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
CI
Pila Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
BioStock: Pila Pharma broadens XEN-D0501 with new indication
AQ
BioStock: Pila Pharma's CEO comments on the Q2 report
AQ
Pila Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
BioStock: Pila Pharma initiates toxicological studies
AQ
Pila Pharma AB Announces the Preclinical Toxicological Three-Month Studies of the Active Substance Xen-D0501 Has Begun
CI
BioStock: Deep dive into Pila Pharma's clinical concept
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PILA Stock
  4. News Pila Pharma AB